Tarsus Pharmaceuticals (TARS) Work In Process (2023 - 2026)

Tarsus Pharmaceuticals' Work In Process history runs 4 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Work In Process rose 113.61% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 113.61% YoY), while the FY2025 annual figure was $1.4 million, up 129.64% from the prior year.
• Work In Process was $1.6 million for Q1 2026 at Tarsus Pharmaceuticals, up from $1.4 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $1.6 million in Q1 2026 to a low of $392000.0 in Q4 2023.
• Historically, Work In Process has averaged $1.1 million across 4 years, with a median of $1.1 million in 2024.
• Biggest YoY gain for Work In Process was 129.64% in 2025; the steepest drop was 37.12% in 2025.
• A 4-year view of Work In Process shows it stood at $392000.0 in 2023, then soared by 56.63% to $614000.0 in 2024, then jumped by 129.64% to $1.4 million in 2025, then gained by 15.74% to $1.6 million in 2026.
• The last three Work In Process figures came in at $1.6 million (Q1 2026), $1.4 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.